Disc Medicine (IRON) investor relations material

Opening remarks and agenda

• The meeting was called to order by the Executive Chairman, with directors and key executives recognized in attendance.

• The agenda included formal business as described in the notice and proxy statement sent to stockholders.

• Representatives from the audit firm and outside counsel were present.

Corporate governance

• Quorum was established with over 35.9 million shares represented out of 38.2 million entitled to vote.

• Voting procedures were explained, and polls were opened for stockholder participation.

• Only stockholders with valid credentials could vote and ask questions.

Board and executive committee updates

• Three nominees were presented for election as Class III directors for a three-year term, with no alternative nominations received.

• The board unanimously recommended the election of the nominated directors.